# Hannah Joseph (NSE: HANNAH) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/HANNAH · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹220 Cr, it ranks 2211th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 13.9% in FY25. Promoters held 71.28% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹220 Cr |
| ROE | 13.9% (FY25) |
| ROCE | 16.5% (FY25) |
| Debt to equity | 0.65 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹78 Cr | ₹7 Cr |
| FY24 | ₹63 Cr | ₹4 Cr |
| FY23 | ₹55 Cr | ₹1 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 71.28%
- Foreign institutions: 0.56%
- Domestic institutions: 9.05%
- Non-institutions: 19.11%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Nath Bio-Genes (India)](https://app.pivotnow.in/stock/NATHBIOGEN) | ₹132.60 | ₹252 Cr | 6.3 | — |
| [BDH Industries](https://app.pivotnow.in/stock/BDH) | — | ₹252 Cr | — | — |
| [Nectar Lifesciences](https://app.pivotnow.in/stock/NECLIFE) | ₹11.34 | ₹220 Cr | — | — |
| [Syschem (India)](https://app.pivotnow.in/stock/SYSCHEM) | — | ₹214 Cr | — | — |
| [Achyut Health](https://app.pivotnow.in/stock/ACHYUT) | — | ₹209 Cr | — | — |
| [Coral Labs](https://app.pivotnow.in/stock/CORALAB) | — | ₹196 Cr | — | — |

## Questions and answers

### What is the market cap of Hannah Joseph?

Hannah Joseph's market capitalisation is ₹220 Cr (₹220 Cr) at the 22 Oct 2026 close, ranking 2211th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Hannah Joseph?

Return on equity was 13.9% in FY25 and return on capital employed was 16.5% in FY25 (standalone figures).

### Is Hannah Joseph a debt-free company?

No. Hannah Joseph's debt-to-equity ratio was 0.65 in FY25, with total debt of ₹28 Cr.

### What is the shareholding pattern of Hannah Joseph?

As of 31 Mar 2026: promoters 71.28%, foreign institutions 0.56%, domestic institutions 9.05%, non-institutions 19.11%.

### Who are Hannah Joseph's competitors?

The listed Pharma & Healthcare companies closest to Hannah Joseph by market cap are Nath Bio-Genes (India), BDH Industries, Nectar Lifesciences, Syschem (India), Achyut Health and Coral Labs.

### Is Hannah Joseph a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Hannah Joseph's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on HANNAH against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.